We previously reported that all-trans retinoic acid (ATRA) inhibits growth in human T-cell leukemia virus type 1 (HTLV-1)-positive T-cell lines and fresh cells from patients with adult Tcell leukemia. However, the mechanism of this inhibition is not clear. In the present study, we observed that NF-jB transcriptional activity as well as cell growth decreased significantly in HTLV-1-positive T-cell lines in the presence of ATRA. Furthermore, we observed that ATRA reduced HTLV-1 proviral DNA, HTLV-1 genes (gag, tax, or pol mRNA) using the real-time quantitative polymerase chain reaction. SIL-2R was reduced by ATRA in both protein level (culture supernantant) and mRNA level in HTLV-1-positive T-cell lines. Interestingly, ATRA significantly inhibited RT activity similar to azidothimidine (AZT) in HTLV-1-positive T-cell lines. Moreover, AZT inhibited proviral DNA but not NF-jB transcriptional activity, and sIL-2R on HTLV-1; however, ATRA inhibited of NF-jB, proviral DNA and sIL-2R on HTLV-1. These results suggested that the decrease in sIL-2R induced by ATRA may be caused by the actions of a NF-jB inhibitor acting on the NF-jB/sIL-2R signal pathway. These results suggested that ATRA could have two roles, as a NF-jB inhibitor and as an RT inhibitor.
Introduction
Adult T-cell leukemia/lymphoma (ATL/ATLL) is an aggressive lymphoid neoplasm associated with human T-cell leukemia virus type 1 (HTLV-1).
1 ATL, the first human disease found to be associated with retroviral infection, usually occurs in native individuals from HTLV-1 endemic regions, that is, southern Japan, the Caribbean, intertropical Africa, and Brazil. 2, 3 The HTLV-1 provirus is clonally integrated in CD4 þ , CD25 þ activated T lymphocytes, which are leukemic cells characteristic of ATL. The exact mechanism of HTLV-1-induced tumorogenesis has not been fully elucidated, although HTLV-1 infection appears to represent the first event in a multistep oncogenic process. 4 Diversity in the clinical features of ATL has been noted and four clinical subtypes of ATL have been defined: the acute form, the chronic form, the smouldering form, and the ATL lymphoma type. 5 The acute and lymphoma types of ATL have a poor prognosis with a median survival of about 6 months. 6 This extremely bad outcome is mainly due to an intrinsic resistance of the leukemic cells to conventional or even high doses of chemotherapy and to a severe immunosuppression. [6] [7] [8] [9] The use of allogenic BMT in the treatment of ATL has been reported, but a high toxicity and transplant-related mortality were observed in immunocompromised patients. [10] [11] [12] [13] A more effective therapy is therefore needed. Vitamin A and its analogs (retinoids) influence the growth and differentiation of normal and malignant cells, and have been shown to possess anticarcinogenic and antitumor activities in vitro and in vivo. 14, 15 Retinoic acid (RA) influences the clonal growth of normal human myeloid cells and induces the differentiation of both HL-60 cells (classified as a cell from a myeloblastic leukemia) and fresh human acute promyelocytic leukemia cells into normal granulocytes. [16] [17] [18] It has been reported that the growth of some tumor cells is inhibited by RA. [19] [20] [21] We previously reported that all-trans RA (ATRA) could induce significant growth inhibition of ATL cells resulting in apoptosis. [22] [23] [24] [25] Tax is a specific gene of ATL that immortalizes human T cells. 26 Tax, a 40 kDa protein, is a transcription transactivator of HTLV-1 that interacts with cellular transcriptional factors to activate HTLV-1 gene expression and HTLV-1 transformation of human T lymphocytes. 26, 27 Tax activates HTLV-1 gene expression by increasing the binding of the cyclic AMP-responsive element-binding protein/activating transcription factor (CREB/ATF) proteins and the coactivator CBP (CREBbinding protein) to the three 21-bp repeats in the long terminal repeat of HTLV-1, 28, 29 and also activates immediate early genes (c-fos, c-jun, egr-1, and egr-2), a receptor gene (IL-2Ra), and cytokine genes (IL-2, IL-6, TGF-b, GM-CSF). 26, 27 Furthermore, tax interacts with the ankyrin motifs in I-kB and NF-kB p105 and dissociates from or interferes with the complex I-kB/NF-kB, which is involved in the transcriptional activation of NF-kB in the cytoplasm. 30 It has also been shown that NF-kB was transported into nuclei and activated to induce the expression of cytokine and receptor genes. 26, 27, 31 Inhibition of NF-kB activity is related to induction of apoptosis, and thus the Rel/NF-kB family plays important roles in the proliferation and differentiation of various cells in vitro. 32 Already, Mori et al 33 have reported that NF-kB is constitutively activated in primary ATL cells as well as in the HTLV-1-positive T-cell line TL-Om1 independent of Tax protein. Furthermore, we previously reported that the target molecule of ATRA may be tax or some molecule in the tax-NF-kB signal pathway. 34 At the present time, the mechanism of ATRA's effect in ATL cells is not clear. In this study, we observed two critical points: (1) whether ATRA suppresses HTLV-1 replication and (2) whether ATRA decreases NF-kB transcriptional activity via a direct reaction. We found that (1) proviral DNA load and RT activity were reduced in HTLV-1-positive T-cell lines by ATRA and (2) ATRA decreased NF-kB transcriptional activity.
Materials and methods
Cell lines, subjects, and cell culture Jurkat and MOLT-4 are human T-cell lines not infected with HTLV-1. ATL-2, HUT102, MT-2, MT-4, and ED40515 are lines of human T cells infected with HTLV-1. MT-2 and MT-4 were kindly provided by Dr M Matsuoka of Kyoto University. ED40515 was a gift from Dr M Maeda of Kyoto University. These cell lines were maintained by culturing them at 371C under a humid atmosphere containing 5% CO 2 in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) (JRH Biosciences, Lenexa, KS, USA).
Reagents
ATRA, azidothimidine (AZT), and phorbol myristate acetate (PMA) were obtained from Sigma (St Louis, MO, USA) and dissolved in 100% ethanol and distilled water in each experiment. Etoposide (VP-16) was obtained from Nippon Kayaku and dissolved in distilled water. In each assay, the control was an equal volume of 100% ethanol for ATRA or distilled water for other reagents excluding ATRA. In all assays, the equal volume of distilled water as well as 100 % ethanol had no effect on HTLV-1-positive T-cell lines.
Proliferation assay
Proliferation was determined by the MTS assay performed in triplicate wells according to the manufacturer's instructions (CellTiter 96 AQ ueous One Solution Cell Proliferation Assay, Promega, Southampton, UK). 35 In brief, cells (1 Â 10 5 /ml) were cultured in flat-bottomed 96-well microplates (Corning, NY, USA) with 10 À5 M ATRA, 64 mM AZT, 2 mg/ml VP-16, or control reagent (equal volume of 100% ethanol or distilled water) for 24, 48, and 72 h. In total, 20 ml of CellTiter 96 AQ ueous One Solution was added and the cells were incubated for an additional 2 h. Fluorescent intensity was measured at 490 nm using an ELISA plate reader (BioRad, Benchmark, Japan).
Real-time polymerase chain reaction (PCR) of DNA and RT-PCR of mRNA DNA and RNA were extracted from HTLV-1-positive T-cell lines after treatment with 10 À5 M ATRA, 64 mM AZT, or 2 mg/ml VP-16 (DNA at 48 and 72 h and RNA at 24, 36, and 48 h) using a SepaGene kit (Sankoujunyaku K.K., Tokyo, Japan). The concentration of extracted DNA was adjusted to 10 ng/ml for the working solution. Complementary DNA (cDNA) was synthesized from RNA of HTLV-1-positive T-cell lines using a TaqMan Gold RT-PCR Kit (Applied Biosystems, Foster City, CA, USA). Primers and probes for HTLV-1 proviral and housekeeping gene (Albumin) were as described previously 36 and summarized in Table 1 . We selected primers and probes for HTLV-1 gag, tax, pol mRNA, and sIL-2R mRNA by using the Primer Express software (Applied Biosystems). We used the primers and probe (Applied Biosystems) for the human housekeeping gene GAPDH at mRNA level for internal calibration. The TaqMan probes contain the fluorophores 5 0 FAM as reporter and 3 0 TAMRA as quencher. PCR conditions were as follows: 10 ml of DNA solution or 10 ml of cDNA solution synthesized from 300 ng of RNA was added to 40 ml of reaction mixture (AmpliTaq Gold; Applied Biosystems). The thermal cycler conditions were 2 min at 501C to activate AmpErase UNG enzyme, 10 min at 951C to inactivate UNG and activate AmpliTaq Gold DNA polymerase, and then 45 cycles of 15 s at 951C (denaturation) followed by 1 min at 601C (annealing and extension). All standard dilutions, controls, and samples were run in triplicate and the average value of the copy number was used to quantify HTLV-1 proviral DNA, albumin DNA, HTLV-1 gag, tax, pol mRNA, sIL-2R mRNA, and GAPDH mRNA. Standard curves for HTLV-1 copies were generated using a 10-fold dilution series of MT-2 DNA. The MT-2 cell line was used as a quantitation control in each run, and acceptable results were considered to be 2.4-3.3 HTLV-1 copies per cell. The normalized value of the HTLV-1 proviral load was calculated as the ratio of (HTLV-1 DNA average copy number/albumin DNA average copy number) Â 2 Â 100 and expressed as the number of HTLV-1 copies per 100 cells. Standard curves for the value of gag, tax, or pol mRNA and GAPDH mRNA were generated using cDNA from MT-2 cells. MT-2 cDNA was serially diluted 10-fold with diethyl pyrocarbonate (DEPC) H 2 O down to a 10 À4 dilution, and sample cDNA from 300 ng of RNA per well was applied and analyzed using this system. All standards and samples were assayed in triplicate. When a serial dilution of 10 0 to 10 À4 of the MT-2 cell cDNA was used as the template for real-time PCR, the specific signal increased in accordance with the increase in PCR cycles, but not in the negative control. The threshold cycle Table 1 Primers and TaqMan Dichotomy of all-trans retinoic acid T Yamaguchi et al values were used to plot a standard curve in which threshold cycle decreased in linear proportion to the log of the template copy number. The correlation values of standard curves were always more than 99%. The relative HTLV-1 gag, tax, pol mRNA, or sIL-2R mRNA load were calculated with the following formula: gag mRNA load ¼ (average value of gag)/ (average value of GAPDH) Â 10 7 (only ED40515) or Â 100 (other four HTLV-1-positive T-cell lines); tax mRNA load ¼ (average value of tax)/(average value of GAPDH) Â 1 (ATL-2 and HUT102), or Â 10 (MT-2 and MT-4); pol mRNA load or sIL-2R mRNA load ¼ (average value of gag or sIL-2R)/ (average value of GAPDH) Â 10 3 .
Isolation of viral particles from HTLV-1-positive T-cell lines by PEG precipitation
Five HTLV-1-positive T-cell lines (1 Â 10 5 /ml: total 20 ml) were cultured in dishes 10 cm in diameter with 10 À5 M ATRA, or 64 mM AZT for 48 and 72 h. The cultured cell lines were adjusted to the same number of cells (1 Â 10 6 ). Then, viral particles were isolated from the cells. The pellets are lysates of retrovirus.
Measurement of RT activity
To investigate the RT inhibitory effects of ATRA, the RT activity of the pellets before and after treatment with ATRA or AZT was determined using Reverse Transcriptase Assay (colorimetric) according to the manufacturer's instructions (Roche; Cat. No. 1828657). Furthermore, to observe direct action of ATRA for RT activity, ATRA or AZT was added to HIV RT, and then RT activity was measured. Briefly, 5 ng recombinant HIV-1-RT was diluted with lysis buffer (20 ml/well) in a separate reaction tube. Lysis buffer with no HIV-1-RT added was used as a negative control and 20 ml of AZT (64 mM) as a RT inhibitor or ATRA (10 À5 or 10 À7 M) diluted in lysis buffer and 20 ml reaction mixture per reaction tube were added and incubate for 1 h at 371C. The samples (60 ml) were transferred into the wells of microtiterplate modules and incubated for 1 h at 371C. Then, the detection and quantification of synthesized DNA as a parameter for RT activity follows a sandwich ELISA protocol according to the kit. All steps of Reverse Transcriptase Assay, including the RT reaction, were performed directly in the microtiterplate modules supplied with the kit. Inhibitory activity of ATRA (10 À5 or 10 À7 M) or AZT (64 mM) as an RT inhibitor was calculated as percent inhibition as compared to sample that does not contain an inhibitor. The Reverse Transcriptase Assay (colorimetric) takes advantage of the ability of RT to synthesize DNA, starting from the template/ primer hybrid poly (A) Â oligo (dT) 15 . This assay is a nonradioactive enzyme immunoassay for the highly sensitive, quantitative determination of RT activity by chemiluminescence detection.
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Plasmids pCD23-CAT, which is a derivative of pCD15-CAT containing the NF-kB responsive elements U3 and R of the HIV long terminal repeat, was provided by Dr T Okamoto of the Nagoya City University. [38] [39] [40] [41] A pSV0CAT vector was used as a control. 42 CAT assay 
Measurement of soluble IL-2 receptor
The five HTLV-1-positve T-cell lines were seeded in a dish 10 cm in diameter with 10 À5 M ATRA, 64 mM AZT, or 2 mg/ml VP-16 for 24, 48, and 72 h. After collection of the culture supernatants, total soluble IL-2 receptor (sIL-2R) was measured using an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (CELL FREE IL-2R TEST KIT; kyouwa medix).
Statistical analysis
Results were expressed as the mean plus standard error. All experiments were performed at least three times with similar findings. The significance of the difference between each experimental sample (treated with 2 mg/ml VP-16, 64 mM AZT, or 10 À5 or 10 À7 M ATRA) and the control (treated with control reagent) was determined using the Student t-test. The level of significance was a P-value less than 0.05.
Results

ATRA induced growth inhibition of HTLV-1-positive T-cell lines
We assessed the effects of ATRA on cell growth in five HTLV-1-positive T-cell lines and two HTLV-1-negative T-cell lines. and control reagent for 48 h using real-time RT-PCR. Table 3 shows that HTLV-1 gag or pol mRNA load was significantly suppressed by ATRA (all five or four HTLV-1-positive Tcell lines at 48 h, respectively). Moreover, HTLV-1 tax mRNA load was significantly suppressed by ATRA (HUT102 and MT-2 at 48 h). HTLV-1 gag or pol mRNA load was more effectively reduced by ATRA than by AZT in HTLV-1-positive T-cell lines (ATL-2 and ED40515 for gag or ATL-2, MT-2, and MT-4 for pol) at 48 h. However, HTLV-1 tax mRNA load was decreased by ATRA as well as AZT in two HTLV-1-positive T-cell lines. In spite of the significant decrease in HTLV-1 gag or pol mRNA load caused by ATRA or AZT treatment in ATL-2, HTLV-1 tax mRNA load was not reduced by ATRA or AZT treatment in ATL-2. However, HTLV-1 gag, pol, and tax mRNA load decreased in MT-4 treated with AZT, but not ATRA.
Inhibition of RT in HTLV-1-positive T-cell lines by ATRA
As ATRA reduced HTLV-1 proviral DNA load, we observed whether it degrades the RT that participates in the cycle of retroviral replication. HTLV-1-positive T-cell lines (1 Â 10 5 /ml: total 20 ml) were cultured with 10 À5 M ATRA, 64 mM AZT, or control reagent. Using the RT detection assay, we measured the RT activity of cell lysates. It was observed that ATRA significantly suppressed the activity in HTLV-1-positive T-cell lines (MT-4 and ED40515 at 48 h, and HUT102, ED40515, MT-2, and MT-4 at 72 h) (Figure 2a) . Moreover, we determined the percent inhibition for RT of ATRA (10 À5 or 10 À7 M) or AZT (64 mM) using the RT detection assay. It was observed that ATRA directly inhibits RT in a dose-dependent manner (Figure 2b ).
Inhibition of NF-kB transcriptional activity by ATRA
Next, we investigated the effects of ATRA for NF-kB transcriptional activity. As shown in Figure 3 , the transcriptional activity of NF-kB in four HTLV-1-positive T-cell lines expressing or not expressing tax mRNA (ATL-2, HUT102, MT-2 and MT-4, or ED40515) was significantly decreased in the presence of ATRA. However, in the presence of AZT, the transcriptional activity was not decreased in HTLV-1-positive T-cell lines. CAT activity in the control vector was not suppressed in the HTLV-1-positive T-cell lines after treatment with ATRA. However, inhibition of NF-kB transcriptional activity was not observed in PMA-stimulated Jurkat and MOLT-4. An asterisk indicates a significant difference (Po0.05) after ATRA or AZT treatment compared with the control culture (medium).
The unit of HTLV-1 proviral DNA load is copy per 100 cells in all cell lines.
Dichotomy of all-trans retinoic acid T Yamaguchi et al ATRA inhibits soluble IL-2 receptor on HTLV-1-positive T-cell lines Figure 4 shows that significant suppression of sIL-2R by ATRA was observed in five HTLV-1-positive T-cell lines, especially in four of the lines (ATL-2, MT-2, MT-4, and ED40515) at 72 h culture. No suppression of sIL-2R was observed after treatment with AZT. Furthermore, to observe sIL-2R mRNA after treatment with each agent, real-time PCR was carried out. As shown in Table 4 , sIL-2R mRNA loads in all five HTLV-1-positive T-cell lines were reduced by ATRA, but not by VP-16 or AZT.
Discussion
We previously reported that ATRA inhibits growth in HTLV-1-positive T-cell lines and fresh lymphocytes from patients with ATL. [22] [23] [24] [25] However, the mechanism involved is not clear. Richard et al 43 have reported that a retinoid-related molecule that does not bind to classical retinoid receptors potently induces apoptosis in human prostate cancer cells through a rapid caspase activation. Considering ATRA signaling for HTLV-1-positive cells, we focused on two critical points relating to the mechanism: (1) whether ATRA decreases NF-kB transcriptional activity and (2) whether ATRA suppresses retroviral replication. In the present study, first, to verify the growth inhibition by 
Dichotomy of all-trans retinoic acid
T Yamaguchi et al ATRA or effect of AZT in antiretroviral therapy, we observed the growth inhibitory effects of HTLV-1-positive cell lines. As shown in Figure 1 , cell growth was inhibited in the HTLV-1-positive Tcell lines following treatment with ATRA or AZT. It was suggested that the growth inhibition by ATRA involved the suppression of viral replication. Next, it is thought that cell growth was promoted by advancement of viral replication in HTLV-1-infected cells. Then, we hypothesized that ATRA may have antiretroviral activity. As shown in Table 2 , interestingly, not only AZT, which is an RT inhibitor, but also ATRA suppressed HTLV-1 proviral DNA load as well as proliferation in HTLV-1-positive T-cell lines, but VP-16 did not suppress HTLV-1 proviral DNA load. These results suggested that ATRA may inhibit the replication of HTLV-1 resulting in growth arrest. Furthermore, we observed that AZT as well as ATRA reduced HTLV-1 gene gag, tax, and pol in mRNA level in HTLV-1-positive T-cell lines (Table 3) . These findings also suggested that the ATRA-induced downreplication of not only gag or pol but tax results in inhibition of HTLV-1 replication. We observed that the rate of inhibition of tax mRNA by ATRA or AZT was lower than that of gag mRNA. This mechanism has not been clarified, and further study will be needed. RT activity in cell lysate significantly decreased in HTLV-1-positive T-cell lines by ATRA as well as AZT treatment (Figure 2) . To observe the direct action of ATRA to RT activity, ATRA was added to HIV RT in a microtiter well, and then RT activity was measured. As shown in Figure 2b , RT activity as well as AZT decreased significantly. These results suggested that ATRA may bind RT directly that results in inhibition of RT activity. Furthermore, we considered the effect of ATRA on NF-kB transcription activity. Previously, Mori et al 33 had reported that NF-kB is constitutively activated in primary ATL cells as well as in the HTLV-1-positive T-cell line TL-Om1 independent of Tax protein. Therefore, the NF-kB is Table 4 sIL-2R mRNA load (copy/1000 cells) in HTLV-1(+) T-cell lines by control, VP-16, AZT, or ATRA using real-time RT-PCR Production of sIL-2R in response to ATRA. HTLV-1-positive T-cell lines were exposed to VP-16 (2 mg/ml), AZT (64 mM), and ATRA (10 À5 M) for 24, 48, and 72 h, then sIL-2R in cell supernants was measured by enzyme-linked immunosorbent assay (ELISA). Data represent the mean7s.d. of three experiments. An asterisk indicates a significant difference (Po0.05) in inhibition of sIL-2R in cell supernatant after ATRA treatment compared with the control culture (medium).
Dichotomy of all-trans retinoic acid T Yamaguchi et al involved in cell growth in HTLV-1-positive T-cell lines. In the present study, as shown in Figure 3 , we found that the transcriptional activity of NF-kB in all five HTLV-1-positive Tcell lines (including ED40515 of an HTLV-1-positive T-cell line that does not express tax mRNA) decreased in the presence of ATRA. However, in the presence of AZT in HTLV-1-positive Tcell lines or in the presence of ATRA in PMA-stimulated T-cell lines, NF-kB transcriptional activity did not decrease. By these results, we speculated that ATRA may have another action in NF-kB inhibition related HTLV-1 replication, compared to AZT. Additionally, in future, we need to study gene level of NF-kB. ATL cells are characterized by the constitutive high-level expression of Tac antigen (IL-2Ra, CD25) . 44 Tax protein activates both the viral LTR and the IL-2Ra gene (CD25), resulting in marked expression of CD25. 45, 46 Enhanced transcription of the IL-2Ra gene by NF-kB is one mechanism that underline the strong expression of CD25. [47] [48] [49] [50] It is reported that the sIL-2 receptor indicates disease progression in ATL. 51 As shown in Figure 4 , ATRA and VP-16 significantly inhibited sIL-2R at protein and mRNA level (Table 4 ), but AZT did not. These results suggested that ATRA may suppress sIL-2R as an NF-kB inhibitor and may be more effective in treating ATL than AZT. In summary, we found that ATRA suppressed the growth of HTLV-1-positive T-cell lines and expression of sIL-2R, which indicate disease progression in ATL. Furthermore, we observed that ATRA could inhibit NF-kB transcriptional activity in HTLV-1-positive T-cell lines, and reduce HTLV-1 proviral DNA, gag, tax, and pol at mRNA level and RT activity of HTLV-1. These results suggest that the mechanism of ATRA's action may be dichotomized into inhibition of NF-kB transcriptional activity related to HTLV-1 and inhibition of RT.
